Urine albumin excretion, within normal range, reflects increasing prevalence of metabolic syndrome in patients with essential hypertension

Journal of Clinical Hypertension

Volumn 12, Issue 8, 2010, Pages 597-602

  Vyssoulis, Gregory ^a   Karpanou, Eva ^b   Spanos, Pangiotis ^a   Kyvelou, Stella Maria ^a   Adamopoulos, Dionysios ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; ADULT TREATMENT PANEL III; ALBUMIN URINE LEVEL; ALBUMINURIA; ARTICLE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; IMMUNONEPHELOMETRY; INTERNATIONAL DIABETES FEDERATION CRITERIA; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; NEPHELOMETRY; NORMAL VALUE; PRIORITY JOURNAL; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; URINE LEVEL; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ALBUMINURIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77955255144     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2010.00306.x     Document Type: Article

References (27)

1. Redon J, Williams B. Microalbuminuria in essential hypertension: redefining the thresholds. J Hypertens 2002, 20:353-355.
2. Gerstein HC, Mann JF, Yi Q. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA 2001, 286:421-426.
3. Jencen JS, Feldt-Rasmusen B. Arterial hypertension, microalbuminuria and risk of ischemic heart disease. Hypertension 2000, 35:898-903.
4. Bigazzi R, Bianchi S, Baldor D. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 1998, 16:1325-1333.
5. Vyssoulis P, Karpanou E, Michaelidis A. Microalbuminuria and global myocardial function in patients with essential hypertensive. Int J Cardiol 2008, 126:268-272.
6. Pedrineli R, Dell'Omo G, Di Bello V. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens 2002, 16:79-89.
7. Podremoli R, Cheli V, Sofia A. Prevalence of micro- and macro-albuminuria and their relationship with other cardiovascular risk factors in essential hypertension. Nephrol Dial Transplant 1995, 16:6-9.
8. Winocour PH, Harland JO, Millar JP. Microalbuminuria and associated risk factors in the community. Atherosclerosis 1992, 93:71-81.
9. Mykkanen L, Zaccaro DJ, Wegenknecht LE. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 1998, 47:793-800.
10. Redon J, Pascual JM. Development of microalbuminuria in essential hypertension. Curr Hypertens Rep 2006, 8:171-177.
11. Hillege HL, Fidler V, Dierks GF. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002, 106:1777-1782.
12. Tsakiris A, Doumas M, Lagatouras D. Microalbuminuria is determined by systolic and pulse pressure over a 12-year period and related to peripheral artery disease in normotensive and hypertensive subjects: the Three Areas Study in Greece (TAS-GR). Angiology 2006, 57:313-320.
13. Klausen K, Borch Johnsen K, Feldt Rasmusen B. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension and diabetes. Circulation 2004, 110:32-35.
14. Arnlof J, Evans JC, Meigs JB. Low grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005, 112:969-975.
15. Mc Neil AM, Rosamond W, Girman C. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005, 28:385-390.
16. Wang J, Ruotsalainen S, Moilanen L. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow up study in elderly nondiabetic Finns. Eur Heart J 2007, 28:857-864.
17. Schillaci G, Pirro M, Vaudo G. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 2004, 43:1817-1822.
18. Wachtell K, Ibsen H, Olsen MH. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE study. Ann Intern Med 2003, 139:901-906.
19. Verdecchia P, Schillaci G, Guerrieri M. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990, 81:528-536.
20. Vyssoulis G, Pietri P, Karpanou E. Differential impact of metabolic syndrome on arterial stiffness and wave reflections: focus on distinct definitions. Int J Cardiol 2010, 138:119-125. Epub 2008 Sep 19
21. Can AS, Bersot TP. Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study. BMC Public Health 2007, 7:353.
22. Macchia A, Levantesi G, Borrelli G. A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring. Am Heart J 2006, 151:754.
23. Mattix HJ, Hsu CY, Shaykevich S. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 2002, 17:81-85.
24. Jacobs DR, Murtaugh MA, Steffes M. Gender- and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens: the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol 2002, 155:1114-1119.
25. Danziger J. Importance of low-grade albuminuria. Mayo Clin Proc 2008, 83:806-812.
26. Pascual JM, Rodilla E, Gonzalez C. Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension 2005, 45:1125-1130.
27. Schrier RW, Estacio RO, Esler A. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002, 61:1086-1097.